HealthJobsUK

Job overview

We are pleased to announce this exciting opportunity to recruit one full time research nurse (B7) to join the Queen Square MND Centre, Neuromuscular Diseases (CNMD), the largest clinical and research centre in the UK for patients with muscle wasting disease such as motor neuron disease, muscular dystrophy and peripheral neuropathy. The development of clinical trials is one of the priorities of the centres, and the post holder will work on trials in neuromuscular diseases. In the last decade, a significant progress in research and investment in clinical trials has driven the development of new therapeutics for MND. This post will be at the centre of newly created research and clinical trial networks like United To End MND (U2EM) and the MND Research Institute

The post holder will have overall responsibility for one or more multi-disciplinary clinical studies in the Queen Square MND Centre, including clinical trials and observational studies. The appointee will be expected to play a major role in overseeing and be responsible for the day-to-day management of conducting clinical drug trials as part of the MND Centre, work closely with our clinical trial research coordinator(s), existing research nursing staff, principal investigators, physiotherapists, research support staff and the research team at the Leonard Wolfson Experimental Neurology Centre (LWENC) to ensure compliance with Trust Policy, Good Clinical Practice (GCP), Human Tissue Act (HTA), and trial specific protocols.

Main duties of the job

This varied and challenging post, will involve, among other tasks: acting as a first point of contact for potential and recruited patients, entering patients into the database, ensuring that all necessary study procedures and assessments are performed, take responsibility for supporting the monitoring of safety of the study participants and reporting events as required by protocol, and liaise with multidisciplinary colleagues to ensure the smooth operation of the trials, and in compliance with the protocols and relevant legislation. The post-holder would also be expected to support where necessary the preparation of regulatory submissions in conjunction with the trials coordinators attached to the Centre for Neuromuscular Diseases. The post-holder will also have an important role in the running of our observational studies, longitudinal collections of clinical data and biological samples that support the development of new biomarkers. This will include both face to face encounters and remote recruitment/collection and close contact with our clinical nurses and laboratory technicians. Both clinical trials and observational studies are developed in collaboration with several research Institutes in the UK. The post-holder will be expected to collaborate with clinical research nurses and PIs from other Institutes.  

Working for our organisation

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.     

We provide first-class acute and specialist services across eight sites:     

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)   
• National Hospital for Neurology and Neurosurgery  
• Royal National ENT and Eastman Dental Hospitals  
• University College Hospital Grafton Way Building  
• Royal London Hospital for Integrated Medicine   
• University College Hospital Macmillan Cancer Centre   
• The Hospital for Tropical Diseases  
• University College Hospital at Westmoreland Street  

We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.    

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.